Tozadenant Terminated Phase 1 Trials for Hepatic Impairment (HI) Basic Science

IndicationsStatusPurposePhase
TerminatedBasic Science1
clinicaltrials.gov IdentifierTitleDrugs
NCT03212313
Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of Tozadenant